The first-order degradation kinetics of epidoxorubicin were investigated as a function of pH, temperature, and buffers concentrations. The degradation was followed by HPLC. Buffer catalysis was observed in acetate and phosphate buffers. The pH-rate profiles were obtained at 333, 343, 353, and 363 K. The pH-rate expression was pH
Introduction
Epidoxorubicin hydrochloride (EP) is the most commonly used anthracycline antitumor antibiotic consisting of a tetracyclic quinolid aglycone connected by a glycoside bond with an amino sugar-L-acosamine. The drug is structurally related to doxorubicin and the difference between them is in the stereochemistry of the C-4 hydroxyl group of the sugar moiety. Due to its structure, EP demonstrates lower cardiotoxicity and so it can be used in higher doses [1] [2] [3] . The lower efficiency and higher toxicity of drugs can be also associated with degradation during their storage or clinical use (e.g., long-term infusions). EP is produced as powder or solutions for injections and administered as long-term infusions. Therefore, it is important to investigate its stability both in the solid phase and in solutions.
The influence of temperature and relative air humidity on the stability of EP as well as of doxorubicin and daunorubicin in the solid state was previously reported [4, 5] . The degradation of EP in the atmosphere of increased relative air humidity was a first-order reaction depending on the substrate concentration, and in dry, hot air (RH 0%; 393 K) a reversible first-order reaction relative to the substrate concentration. The dependences ln = (1/ ) and ln = (RH%) were described by the equations ln = (35.1±10.9)− (16250 ± 3823)(1/ ) and ln = (3.79 ± 3.34) × 10 −2 (RH%) − (12.9 ± 2.4), respectively, and the kinetic and thermodynamic parameters of the above processes were calculated [4] .
The photodegradation [6] and hydrolysis of EP under acidic (0.05 M; 363 K) and basic (0.05 M; 303 K) conditions [7] were first-order reactions. The photodegradation rate was inversely proportional to the concentration of the drug and rose as the solvent pH increased. In the case of concentrations which are used in chemotherapy (>500 mcg/mL), protection from light was not necessary [6] .
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The stability of EP was also assessed in sodium chloride solutions (0.9% NaCl, pH 5.20 and 6.47) and in dextrose (5%; pH 4.36) at 25 ∘ C, 4 ∘ C, and −20 ∘ C, stored in polyvinyl chloride (PCV) minibags, which are no longer in clinical use, and in water for injections, stored at 4 ∘ C in polypropylene syringes [8] . The drug was stable (loss below 10%) under the above conditions with the exception of storage in 0.9% NaCl (pH 6.47) at 25 ∘ C, when degradation exceeding 10% was observed after 43 days. It was also found that the repeated freezing and defrosting of these solutions stored in minibags did not cause significant degradation and that polypropylene appeared to be the best material for EP storing [8] .
During the storage of EP injections at pH 3 and a temperature of 2-8 ∘ C for 12 months or at 25 ∘ C for 6 months, some degradation products were observed [9] . Three products were isolated and characterized by NMR and LC-MS/MS methods. Product I (dimer of EP) was formed due to the condensation of two EP molecules. Product III (4-(4-amino-5-hydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-naphthacene-2-carboxylic acid hydroxymethyl ester) was produced by oxidative rearrangement of EP in the side chain under acidic conditions. After hydrolysis of the ester group of degradation product III, product IV (4-(4-amino-5-hydroxy-6-methyltetrahydro-pyran-2-yloxy)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-naphthacene-2-carboxylic acid) was formed, which can also be directly produced due to the oxidation of the side chain of EP and the elimination of the ester moiety [9] .
The literature does not refer to comprehensive kinetic studies of EP in aqueous solutions in a wide range of pH values and temperatures. Thus, the aim of this study was to evaluate the degradation of EP under the influence of pH and temperature and to develop equations permitting the estimation of kinetic and thermodynamic parameters. To separate EP and its degradation products, our previously designed HPLC method was used [4] . The geometric structure of EP molecule, FMOs orbitals (HOMO-LUMO; Highest Occupied Molecular Orbital; Lowest Unoccupied Molecular Orbital), and molecular electrostatic potential were also determined.
Experimental

Materials and Reagents.
Epidoxorubicin hydrochloride was synthesized at the Department of Modified Antibiotics, Institute of Biotechnology and Antibiotics, Warsaw, Poland. Sodium laurilsulfate (A.C. reagent, Sigma-Aldrich Logistik GmbH, Germany) and all other chemicals and solvents were obtained from Merck KGaA, Germany, and were of analytical or high-performance liquid chromatographic grade.
Chromatographic Conditions.
Chromatographic separation and quantitative analysis were performed by using the HPLC method [4] . The analytical system consisted of a Shimadzu SPD-20A Prominence UV/VIS detector, a Rheodyne with a 50 L loop. An LiChrospher RP-18 column (250 mm × 4 mm, 5 m particle size, Merck, Germany) was used as the stationary phase. The mobile phase consisted of equal volumes of acetonitrile and a solution containing 2.88 g/L of sodium laurilsulfate and 2.25 mL/L of phosphoric acid. The flow rate was 1.0 mL/min and UV detection was performed at 254 nm. As the HPLC method was previously evaluated and validated for a stability study of epidoxorubicin in the solid state [4] , selectivity was examined during stability studies in aqueous solutions in this work. Papaverine hydrochloride was used as an internal standard at a concentration of 0.05 mg/mL.
Kinetic Procedures.
The degradation of EP in aqueous solutions was studied at 333 K, 343 K, 353 K, and 363 K in the pH range 0.42-9.95. The pH values of the reaction solutions and those of the buffer standards were measured at reaction temperatures. The pH values of the reaction solutions in HCl were calculated from the equation pH = − log HCl [HCl] . The activity coefficient HCl was obtained or calculated from the literature data [10] . The ionic strength of all the solutions was adjusted to 0.50 M with a solution of sodium chloride (4 M). Solutions of the desired pH and ionic strength of 0.50 M were heated to the required temperatures and then a sample of EP was added to obtain the initial concentration of 0.2 mg/mL. At selected times, determined by the rate of degradation, samples of the solutions (1.0 mL) were collected and instantly cooled with a mixture of ice and water. Samples with pH above 7.5 were neutralized by using HCl solutions at concentrations ensuring that their pH was approximately 2. To each such sample, 1.0 mL of the internal standard solution (papaverine hydrochloride solution) was added. 50 L of the solution samples was injected into the column. Due to the fact that anthracyclines are photolabile, all samples to be studied were protected from light.
Microsoft Excel 2000 was used for the calculation of regression parameters.
Theoretical Studies.
In order to interpret the FMOs (frontier molecular orbitals) and EP, quantum-chemical calculations were performed by using the Gaussian 03 package [11] . The GaussView software was utilized to propose the initial geometry of the investigated molecules. The molecular geometries were optimized by means of a density functional theory (DFT) method with the B3LYP hybrid functional and a 6-31G(d,p) basis set.
Results and Discussion
Observed Rate Constants.
The observed rate constants of EP degradation in aqueous solutions were determined in a pH range of 0.42-9.95 and described by the equation of a pseudo-first-order reaction:
where and 0 are the time-dependent concentration and the initial concentration of EP at times > 0 and = 0, respectively; obs is the observed rate constant of the pseudofirst-order reaction of EP degradation. The number of measurements of for each series ranged from 8 to 12.
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Buffer Catalysis.
Under the conditions of this study, the rate constants ( obs ) depended on the total concentrations of the phosphate and acetate buffers, which indicated that the components of the buffers catalyzed the degradation of EP (general acid-base catalysis). In order to verify that the differences between obs determined at different buffer concentrations were statistically significant, the parallelism test was used. Under the conditions of general acid-base catalysis, obs were calculated from the following equation:
where [ ] is the total buffer concentration, pH is the rate constant at zero buffer concentration, and describes the catalytic effect of the buffer components. The catalytic effect of the acetate buffer was investigated at pH 4.02-5.89 while those of phosphate buffers were investigated at pH 2.15-3.40 ( Figure 1 ) and pH 5.91-7.45. Since in the reaction solutions of EP in HCl and borate buffer general acid-base catalysis was not observed, in that pH range, the values of obs = pH .
pH-Rate Profiles.
The values pH calculated from (2) under the conditions of general acid-base catalysis (acetate and phosphate buffers) and those obtained for hydrochloric acid as well as borate buffer ( obs = pH ) were used to calculate the relationship log pH = (pH) (Figure 2 The total reaction rate was equal to the sum of partial reaction rates:
where H + is the hydrogen ion activity and 1 -3 are the fractions of protonated and unprotonated molecules and monoanions of EP. The 1 -3 values were calculated by using the values of pK of EP that were about 7.4 and 9.5. The catalytic rate constants ( 1 ) were calculated from the plots pH = ( H + ) by using the values of pH in the pH range 0.42−3.40. The plots were linear with the positive slope that equaled 1 (Figure 3) .
The catalytic rate constants 4 and 5 were calculated from the equation pH = pH − ( 1 × H + × 1 ) = ( 4 × 2 + 5 × 3 ) × OH − using pH values above pH 8.5 where the concentrations of 2 + 3 → 1. The plots pH /( OH − × 3 ) = ( 2 / 3 ) were linear with positive slopes equal to the catalytic rate constant 4 and the value corresponded to the catalytic rate constant 5 . The catalytic rate constants 2 and 3 were calculated from the following equation:
, using the pH values at pH 2.8-7, where the concentrations of 1 + 2 → 1.
The plots pH / 1 = ( 2 / 1 ) were linear with positive slopes equal to the catalytic rate constant 3 and the value corresponded to the catalytic rate constant 2 .
The calculated theoretical profile of log = (pH) and that obtained from the experimental results were nearly identical, indicating that the choice of the equation describing the total rate of EP degradation was correct (Figure 2 ). Table 1) .
The lowest energy of activation was observed in the reactions of unprotonated molecules and monoanions of EP catalyzed by hydroxide ions whereas the highest energy of activation was observed in the reaction of protonated molecules of EP catalyzed by hydrogen ions.
Theoretical Studies.
Based on theoretical calculations, the places in EP molecules that might be connected with the differences in EP reactivity in solutions with various pH values were proposed. The electrons in EP were concentrated in the tetracyclic quinolid aglycone, especially in the C ring. That domain was responsible for the reactivity of EP during base hydrolysis (Figure 4) .
The calculations also indicated that the A ring of the tetracyclic quinolid aglycone played a part in EP susceptibility to degradation during acidic hydrolysis. A comparison of electron distribution in the HOMO and LUMO of EP demonstrated that it was similar to electron distribution in daunorubicin and doxorubicin ( Figure 5 ). Previous stability studies of those three anthracycline antibiotics did not show any statistically significant differences between their degradation rate constants in the solid state [4, 5] and revealed a similarity between the relationships log pH = (pH), which correlates with theoretical study results [12, 13] . The values of energy gap for the three derivatives were 3.1 eV, proving their similar chemical stability.
Although the stereoisomerism of the C-4 hydroxyl group of L-acosamine in EP differs from that observed for DOX, the difference does not significantly influence EP reactivity and, consequently, the susceptibility of EP to degradation during acid-base hydrolysis is not affected. That difference 6 Journal of Chemistry in stereoisomerism was crucial for ensuring the greater therapeutic safety of EP.
